Palittiya Sintusek

Ms. Palittiya Sintusek

Chulalongkorn University
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in World Journal of Gastroenterology
Verified
Journal Article
Closed access
DTDuc Long Tran
Duc Long Tran
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
Functional constipation (FC) is considered the most common functional gastrointestinal disorder in children with a pooled global prevalence of 14.4% (95% confidence interval: 11.2-17.6) when diagnosed based on the Rome IV criteria. Its pathophysiological mechanisms are thought be multifactorial and complicated, resulting in difficult management. Currently, the most effective medication, when used in parallel with toilet training, is osmotic laxatives. Children's adherence to medication and parental concern regarding long-term laxative use are the main contributors to treatment failure. Recently, novel therapies with a high safety profile have been developed, such as probiotics, synbiotics, serotonin 5-hydroxytryptamine 4 receptor agonists, chloride channel activators, and herbal and transitional medicines; nonetheless, well-designed research to support the use of these therapies is needed. This review aims to focus on multiple aspects of FC in children, including global prevalence, pathogenesis, diagnostic criteria, tools, as well as conventional and novel treatment options, such as non-pharmacological management, including adequate fiber and fluid intake, physiotherapy, or neuromodulators. We also report that in very difficult cases, surgical intervention may be required.

7 March 2024 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SESutha Eiamkulbutr
Sutha Eiamkulbutr
CTChomchanat Tubjareon
Chomchanat Tubjareon
ASAnapat Sanpavat
Anapat Sanpavat
TPTeerasak Phewplung
Teerasak Phewplung
NSNimmita Srisan
Nimmita Srisan
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
Several diseases originate from bile duct pathology. Despite studies on these diseases, certain etiologies of some of them still cannot be concluded. The most common disease of the bile duct in newborns is biliary atresia, whose prognosis varies according to the age of surgical correction. Other diseases such as Alagille syndrome, inspissated bile duct syndrome, and choledochal cysts are also time-sensitive because they can cause severe liver damage due to obstruction. The majority of these diseases present with cholestatic jaundice in the newborn or infant period, which is quite difficult to differentiate regarding clinical acumen and initial investigations. Intraoperative cholangiography is potentially necessary to make an accurate diagnosis, and further treatment will be performed synchronously or planned as findings suggest. This article provides a concise review of bile duct diseases, with interesting cases.

10 March 2023 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
PDF file
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
NWNasamon Wanlapakorn
Nasamon Wanlapakorn
YPYong Poovorawan
Yong Poovorawan
Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) is the primary cause of chronic HBV infection worldwide. MTCT prevention and antiviral treatment of infected individuals could eliminate this public health burden. Antiviral treatment of hepatitis B surface antigen (HBsAg)-positive pregnant women and immunoprophylaxis with HBV vaccine and hepatitis B immune globulin are the most effective strategies to interfere with MTCT of HBV. However, for worldwide application of those strategies, feasibility, availability, cost, safety, and effectiveness should be considered. Cesarean section and breastfeeding avoidance in hepatitis B e antigen-positive mothers with a high viral load and without antiviral therapy during pregnancy could be an option, but more supporting evidence is needed. HBsAg screening of all pregnant women is recommended when initiating antiviral therapy and immunoprophylaxis for MTCT prevention, except in areas with limited resources. Timely HBV vaccination series administered soon after birth might be the mainstay of prevention. This review aimed to provide a concise update on the effectiveness of available strategies to prevent MTCT of HBV.

9 June 2023 in World Journal of Clinical Pediatrics
Verified
Journal Article
Open access
SESutha Eiamkulbutr
Sutha Eiamkulbutr
TDTermpong Dumrisilp
Termpong Dumrisilp
ASAnapat Sanpavat
Anapat Sanpavat
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
Prevalence of gastroesophageal reflux disease in children with extraesophageal manifestations using combined-video, multichannel intraluminal impedance-pH study

21 March 2016 in Hepatology
Verified
Journal Article
Open access
PDF file
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
ADAnil Dhawan
Anil Dhawan
Click on the article title to read more.

15 November 2021 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
TPTeerasak Phewplung
Teerasak Phewplung
ASAnapat Sanpavat
Anapat Sanpavat
YPYong Poovorawan
Yong Poovorawan
Liver tumors in children with chronic liver diseases